a month ago
LLY
AnalystsMohit BansalMohit Bansal's Stock Forecasts
AnalystsMohit Bansal
Analyst Ranking
Top 8%
#331 out of 4670 analysts
Average Return
+15.37%
Win Rate
67%47 out of 70
Risk vs Reward
Poor
Good
Mohit Bansal's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Avexis IncAVXS | +199.09% | $72.83 | $217.83 | 2017-05-23 - 2018-05-15 | Strong Buy |
Avantor IncAVTR | +175.70% | $10.41 | $28.70 | 2020-03-20 - 2021-03-19 | Strong Buy |
Eli Lilly & CoLLY | +132.66% | $324.49 | $754.95 | 2023-03-13 - 2024-03-12 | Strong Buy |
Avexis IncAVXS | +127.47% | $95.76 | $217.83 | 2017-10-02 - 2018-05-15 | Strong Buy |
Eli Lilly & CoLLY | +89.63% | $425.79 | $807.43 | 2023-05-26 - 2024-05-24 | Strong Buy |
Mohit Bansal Analyst Color
Get additional color on Mohit Bansal's coverage of popular stocks
2 months ago
BMRN
3 months ago
HALO
4 months ago
BMRN
5 months ago
NBIX
7 months ago
LLY
8 months ago
LLY
a year ago
PFE
a year ago
PFE
a year ago
LLY
a year ago
LLY
a year ago
VRTX
a year ago
LLY
a year ago
LLY
a year ago
PFE
2 years ago
PFE
2 years ago
MRK
2 years ago
LLY
2 years ago
PFE
2 years ago
ABBV
3 years ago
MRK
3 years ago
PFE
Mohit Bansal's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Ironwood Pharmaceuticals IncIRWD | 3 | Strong Buy | $12.00 | +166.08% | Maintains | a month ago |
Eli Lilly & CoLLY | 15 | Strong Buy | $1,000.00 | +10.78% | Maintains | a month ago |
Amgen IncAMGN | 6 | Hold | $335.00 | +4.50% | Downgrades | a month ago |
Regeneron Pharmaceuticals IncREGN | 10 | Strong Buy | $1,200.00 | +6.05% | Maintains | a month ago |
Biogen IncBIIB | 9 | Hold | $225.00 | +12.05% | Maintains | a month ago |
Jazz Pharmaceuticals PLCJAZZ | 1 | Hold | $120.00 | +12.00% | Maintains | a month ago |
Pfizer IncPFE | 9 | Hold | $30.00 | +5.04% | Maintains | a month ago |
Merck & Co IncMRK | 9 | Hold | $125.00 | +6.08% | Maintains | a month ago |
Abbvie IncABBV | 4 | Strong Buy | $205.00 | +6.00% | Maintains | a month ago |
Biomarin Pharmaceutical IncBMRN | 3 | Strong Buy | $115.00 | +36.77% | Maintains | 2 months ago |
Vertex Pharmaceuticals IncVRTX | 8 | Strong Buy | $555.00 | +18.59% | Maintains | 3 months ago |
Halozyme Therapeutics IncHALO | 4 | Strong Buy | $58.00 | -2.04% | Maintains | 3 months ago |
Neurocrine Biosciences IncNBIX | 7 | Strong Buy | $170.00 | +41.47% | Upgrades | 5 months ago |
Bristol Myers Squibb CoBMY | 7 | Hold | $52.00 | +6.78% | Maintains | 5 months ago |
Gilead Sciences IncGILD | 7 | Hold | $78.00 | -0.91% | Maintains | 6 months ago |
Travere Therapeutics IncTVTX | 3 | Hold | $9.00 | -18.03% | Maintains | 7 months ago |
Chinook Therapeutics IncKDNY | 1 | Hold | $40.00 | N/A | Downgrades | a year ago |
Cerevel Therapeutics Holdings IncCERE | 3 | Strong Buy | $30.00 | N/A | Upgrades | a year ago |
Mineralys Therapeutics IncMLYS | 1 | Strong Buy | $27.00 | N/A | Initiates Coverage On | 2 years ago |
Xenon Pharmaceuticals IncXENE | 1 | Strong Buy | $50.00 | N/A | Initiates Coverage On | 2 years ago |
9 Meters Biopharma IncNMTRQ | 1 | Strong Buy | $60.00 | N/A | Initiates Coverage On | 3 years ago |
Forte Biosciences IncFBRX | 1 | Strong Buy | $1,875.00 | N/A | Initiates Coverage On | 3 years ago |
Gracell Biotechnologies IncGRCL | 1 | Strong Buy | $35.00 | N/A | Initiates Coverage On | 4 years ago |
Radius Health IncRDUS1 | 1 | Strong Buy | $30.00 | N/A | Maintains | 4 years ago |
Alexion Pharmaceuticals IncALXN | 1 | Hold | $175.00 | N/A | Downgrades | 4 years ago |
Shattuck Labs IncSTTK | 1 | Strong Buy | $36.00 | N/A | Initiates Coverage On | 4 years ago |
Myokardia IncMYOK | 1 | Hold | $225.00 | N/A | Downgrades | 4 years ago |
Adaptimmune Therapeutics PLCADAP | 1 | Strong Buy | $5.00 | N/A | Maintains | 4 years ago |
Calithera Biosciences IncCALA | 2 | Strong Buy | $140.00 | N/A | Maintains | 4 years ago |
Avantor IncAVTR | 1 | Strong Buy | $11.00 | N/A | Maintains | 4 years ago |
Audentes Therapeutics IncBOLD1 | 2 | Hold | $28.00 | N/A | Maintains | 6 years ago |
Avexis IncAVXS | 2 | Strong Buy | $116.00 | N/A | Maintains | 7 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.